Antibodies against peripheral myelin glycolipids in people with HIV infection

Immunology and Cell Biology

Volumn 76, Issue 6, 1998, Pages 535-541

  Petratos, Steven ^a   Turnbull, Victor J ^a   Papadopoulos, Roula ^a   Ayers, Margaret ^b   Gonzales, Michael F ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antibodies; Demyelination; Galactocerebroside; Gangliosides; HIV associated peripheral neuropathy; Sulphatide

Indexed keywords

AUTOANTIBODY; EPITOPE; GALACTOSYLCERAMIDE; GANGLIOSIDE; GLYCOLIPID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELIN; SULFATIDE;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PERIPHERAL NEUROPATHY; THIN LAYER CHROMATOGRAPHY;

CD4-POSITIVE T-LYMPHOCYTES; CHROMATOGRAPHY, THIN LAYER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GANGLIOSIDES; GLYCOLIPIDS; HIV ANTIBODIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE COUNT; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032408722     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00778.x     Document Type: Article

References (34)

1. Snider WD, Simpson DM, Nielson S, Gold JWM, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome, analysis of 50 patients. Ann. Neurol. 1983; 14: 403-18.
2. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immune deficiency syndrome (AIDS), experience at UCSF and review of the literature. J. Neurosurg. 1985; 62: 475-95.
3. So YT, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Arch. Neurol. 1988; 45: 945-8.
4. Simpson DM, Wolfe DE. Neuromuscular complications of HIV infection and its treatment. AIDS 1991; 5: 917-26.
5. Kiprov D, Pfaeffl W, Parry G, Lippert R, Lang W, Miller R. Antibody-mediated peripheral neuropathies associated with ARC and AIDS. Successful treatment with plasmapheresis. J. Clin. Apheresis 1988; 4: 3-7.
6. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity Mortality Weekly Report 41, RR-17. 1992.
7. 1 and sulphatide of peripheral nerve myelin. J. Neurol. 1991; 238: 75-9.
8. 1 antibodies in patients with Guillain Barré J syndrome. J. Neurol. Neurosurg. Psychiatry 1992; 55: 8-11.
9. van den Berg LH, Lankcamp CLAM, de Jager AF. et al. Anti-sulphatide antibodies in peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 1993; 56: 1164-8.
10. Geczy CL, Roberts IM, Meyer P, Bernard CCA. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities. J. Immunol. 1984; 133: 3026-36.
11. Suzuki K. The pattern of mammalian brain gangliosides-II. Evaluation of the extraction procedures, post-mortem changes and the effect of formalin preservation. J. Neurochem. 1965; 12: 629-38.
12. Hirabayashi Y, Suzuhi T, Suzuki Y et al. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J. Biochem. 1983; 94: 327-30.
13. Mezin P, Brion J-P, Vermont J, Micoud M, Stoebner P. Ultrastructural changes associated with peripheral neuropathy in HIV/AIDS. Ultrastruct. Pathol. 1991; 15: 593-602.
14. de la Monte SM, Gabuzda DH, Ho DD et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 1988; 23: 485-92.
15. Przedborski S, Liesnard C, Voordecker P et al. Inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection. J. Neurol. 1988; 235-359 61.
16. Vital A, Beylot M, Vital C, Delors B, Bloch B, Julien J. Morphological findings on peripheral nerve biopsies in 15 patients with human immunodeficiency virus infection. Acta Neuropathol. 1992; 83: 618-23.
17. Vedeler CA, Matre R, Nyland H. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. Acta Neurol. Scand. 1988; 78: 401-7.
18. Husstedt IW, Grotemeyer KH, Busch H, Walter Z. Progression of distal-symmetric polyneuropathy in HIV infection, a prospective study. AIDS 1993; 7: 1069-73.
19. Pestronk A, Li F, Griffin J et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991; 41: 357-62.
20. Nemni R, Fazio R, Quattrini A, Lorenzetti I, Mamoli D, Canal N. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J. Neuroimmunol. 1993; 43: 79-86.
21. Quattrini A, Carbo M, Dhaliwal SK et al. Anti-sulfatide antibodies in neurological disease, binding to rat dorsal root ganglia neurons. J. Neurol. Sci. 1992; 112: 152-9.
22. Bush MS, Reid AR, Allt G. Blood-nerve barrier: Distribution of anionic sites on the endothelial plasma membrane and basal lamina of dorsal root ganglia. J. Neurocytol. 1991; 20: 759-68.
23. Scaravilli F, Sinclair E, Arango J-C, Manji H, Lucas S, Harrison JG. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol. 1992; 84: 163-70.
24. 1 in motor nerve myelin isolated from cauda equina. J. Neurochem. 1992; 59: 1844-9.
25. Cornblath DR, McArthur JC, Kennedy PGE, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotrophic virus type III infection. Ann. Neurol. 1987; 21: 32-40.
26. 1 ganglioside antibodies in neuromuscular diseases: A study of 180 sera. J. Neuroimmunol. 1991; 32: 223-30.
27. 1 antibodies. Ann. Neurol. 1994; 35: 234-7.
28. Ogawa-Goto K, Ohta Y, Kubota K et al. Glycosphingolipids of human peripheral nervous system myelins isolated from cauda equina. J. Neurochem. 1993; 61: 1398-103.
29. Allison JM. Unresponsiveness to self antigens. Lancet 1971; 2: 1401-3.
30. Webb HE, Fazakerley JK. Can viral envelope glycolipids produce autoimmunity, with reference to the CNS and multiple sclerosis? Neuropathol Appl. Neurobiol. 1984; 10: 1-10.
31. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983; 309: 453-8.
32. Katz IR, Krown SE, Safai B, Oettgen HF, Hoffmann MK. Antigen-specific and polyclonal B-cell responses in patients with AIDS. Clin. Immunol. Immunopathol. 1986; 39: 359-67.
33. Zolla-Pazner S. Immunological abnormalities in infections with the human immunodeficiency virus. Lab. Med. 1986; 17: 685-9.
34. Pollard JD, Westland KW, Harvey GK et al. Activated T cells of nonneuronal specificity open the blood-nerve barrier to circulating antibody. Ann. Neurol. 1995; 37: 467-75.